mRNA-based vaccines and therapeutics are transforming the medical landscape by offering effective, targeted solutions for the prevention and treatment of various diseases. To generate these therapies, scientists require a simple and flexible workflow to synthesize high-quality capped mRNA and deliver it safely and efficiently in vivo.
Download this application note to learn about
- The advantages of an optimized mRNA synthesis kit
- The differences between the Cap 1 and Cap 0 structures
- The benefits of modifying mRNA and removing double-stranded RNA by-products
- The in vivo performance of the synthesized mRNA when delivered using lipid nanoparticles
